StockData
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM) stock

MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$96.13+0.62 (+0.65%)

Close on Nov 20, 2026Market cap $6.24BP/E –Yield –

Mirum Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Mirum Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$228.74M, down 2751.5% year over year. For fiscal 2025 it was $54.87M, up 488.0% from the year before. The highest annual figure on record is $54.87M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$54.87M+488.0%
FY2024Dec 31, 2024$9.33M–
FY2023Dec 31, 2023-$71.05M–
FY2022Dec 31, 2022-$120.41M–
FY2021Dec 31, 2021-$132.78M–
FY2020Dec 31, 2020-$89.30M–
FY2019Dec 31, 2019-$39.64M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$44.28M-471.6%
Q1 FY2026Mar 31, 2026-$229.43M–
Q4 FY2025Dec 31, 2025$5.47M–
Q3 FY2025Sep 30, 2025$39.49M+938.5%
Q2 FY2025Jun 30, 2025$11.91M–
Q1 FY2025Mar 31, 2025-$2.00M-113.2%
Q4 FY2024Dec 31, 2024-$5.09M–
Q3 FY2024Sep 30, 2024$3.80M–
Q2 FY2024Jun 30, 2024-$4.58M–
Q1 FY2024Mar 31, 2024$15.20M–
Q4 FY2023Dec 31, 2023-$16.62M–
Q3 FY2023Sep 30, 2023-$18.22M–
Q4 FY2022Dec 31, 2022-$34.51M–
Q3 FY2022Sep 30, 2022-$26.04M–
Q2 FY2022Jun 30, 2022-$20.19M–
Q1 FY2022Mar 31, 2022-$39.67M–
Q4 FY2021Dec 31, 2021-$33.15M–
Q3 FY2021Sep 30, 2021-$34.22M–
Q2 FY2021Jun 30, 2021-$40.20M–
Q1 FY2021Mar 31, 2021-$25.21M–
Q4 FY2020Dec 31, 2020-$36.31M–
Q3 FY2020Sep 30, 2020-$17.50M–
Q2 FY2020Jun 30, 2020-$17.05M–
Q1 FY2020Mar 31, 2020-$18.45M–
Q4 FY2019Dec 31, 2019-$13.77M–
Q3 FY2019Sep 30, 2019-$15.39M–
Q2 FY2019Jun 30, 2019-$8.02M–
Q1 FY2019Mar 31, 2019-$2.47M–

More Mirum Pharmaceuticals figures

See a number that looks wrong?